04:00 PM EST, 11/14/2025 (MT Newswires) -- Health care stocks fell late Friday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) easing 0.2%.

The iShares Biotechnology ETF (IBB) rose 0.9%.

In corporate news, Sarepta Therapeutics' ( SRPT ) Elevidys gene therapy will now carry a boxed warning and a restricted indication following reports of fatal acute liver failure in non-ambulatory Duchenne muscular dystrophy patients, the US Food and Drug Administration said Friday. Sarepta shares were up nearly 7%.

Merck ( MRK ) agreed to buy immunotherapy developer Cidara Therapeutics ( CDTX ) for $9.2 billion to expand its respiratory portfolio. Merck ( MRK ) shares added 0.1%, and Cidara surged 105%.

Bristol-Myers Squibb ( BMY ) shares fell 3.9% after the company and Johnson & Johnson ( JNJ ) stopped a Phase 3 trial of their experimental drug milvexian for people recovering from a recent acute coronary syndrome event. Johnson & Johnson ( JNJ ) shares rose 0.4%.

Novo Nordisk ( NVO ) elected Lars Rebien Sorensen as board chair at its extraordinary general meeting. Sorensen succeeds Helge Lund, who stepped down from the board along with several other members. Novo shares fell 2%.